VIVO VENTURES VI AFFIILATES FUND, L.P.
Insider CIK 1400245 · EIGR 10% owner · CBYL 10% owner · SGNT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EIGR Eiger BioPharmaceuticals, | P Buy | 2016-08-18 | 2016-08-22 | 1,364 | $16.00 | $21.8K | 12,996 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | P Buy | 2016-08-18 | 2016-08-22 | 186,136 | $16.00 | $2.98M | 1,774,096 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2016-04-21 | 2016-09-01 | 17 | $13.55 | $230 | 25,320 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2016-04-21 | 2016-09-01 | 2,299 | $13.55 | $31.2K | 3,456,332 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2016-04-21 | 2016-04-25 | 2,299 | $13.55 | $31.2K | 3,456,332 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2016-04-21 | 2016-04-25 | 17 | $13.55 | $230 | 25,320 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2015-11-04 | 2015-11-04 | 532,119 | $15.45 | $8.22M | 3,458,631 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2015-11-04 | 2015-11-04 | 3,898 | $15.45 | $60.2K | 25,337 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2015-11-03 | 2015-11-04 | 66,793 | $16.32 | $1.09M | 3,990,750 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2015-11-03 | 2015-11-04 | 490 | $16.32 | $8.0K | 29,235 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2015-11-02 | 2015-11-04 | 680 | $16.87 | $11.5K | 29,725 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2015-11-02 | 2015-11-04 | 92,843 | $16.87 | $1.57M | 4,057,543 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 387,960 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 304,438 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 2,230 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 2,476,452 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 2,842 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 18,142 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-24 | 2,476,452 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-24 | 2,230 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-24 | 18,140 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-24 | 2,842 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-24 | 387,960 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-24 | 304,438 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 2,476,452 | — | $0 | 2,476,452 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 2,842 | — | $0 | 2,885,396 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 304,438 | — | $0 | 3,189,834 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 2,230 | — | $0 | 3,192,064 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 387,960 | — | $0 | 2,882,554 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 18,142 | — | $0 | 2,494,594 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-14 | 7,364 | $5.00 | $36.8K | 4,204,564 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-14 | 1,005,136 | $5.00 | $5.03M | 4,197,200 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-24 | 1,005,136 | $5.00 | $5.03M | 4,197,198 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-24 | 2,230 | — | $0 | 3,192,062 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-24 | 304,438 | — | $0 | 3,189,832 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-24 | 7,364 | $5.00 | $36.8K | 4,204,562 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-24 | 387,960 | — | $0 | 2,882,552 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-24 | 18,140 | — | $0 | 2,494,592 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-24 | 2,476,452 | — | $0 | 2,476,452 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-24 | 2,842 | — | $0 | 2,885,394 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2013-09-16 | 2013-09-17 | 618,171 | $21.25 | $13.14M | 4,150,386 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2013-09-16 | 2013-09-17 | 4,529 | $21.25 | $96.2K | 30,405 | SEC↗ |